Diebold Nixdorf, Incorporated
DBD
$79.77
-$1.47-1.81%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.81B | 3.69B | 3.67B | 3.70B | 3.75B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.81B | 3.69B | 3.67B | 3.70B | 3.75B |
| Cost of Revenue | 2.80B | 2.75B | 2.74B | 2.76B | 2.80B |
| Gross Profit | 1.00B | 940.20M | 934.10M | 935.40M | 947.80M |
| SG&A Expenses | 585.00M | 593.50M | 589.60M | 583.60M | 583.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.70M | -1.20M | 200.00K | -1.70M | -1.00M |
| Total Operating Expenses | 3.47B | 3.43B | 3.42B | 3.43B | 3.47B |
| Operating Income | 336.30M | 262.70M | 256.60M | 265.40M | 276.30M |
| Income Before Tax | 121.50M | 71.00M | 27.90M | 57.20M | 49.80M |
| Income Tax Expenses | 24.10M | 17.70M | 38.00M | 65.20M | 64.30M |
| Earnings from Continuing Operations | 97.40 | 53.30 | -10.10 | -8.00 | -14.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.80M | -2.70M | -2.80M | -2.20M | -2.00M |
| Net Income | 94.60M | 50.60M | -12.90M | -10.20M | -16.50M |
| EBIT | 336.30M | 262.70M | 256.60M | 265.40M | 276.30M |
| EBITDA | 452.50M | 394.20M | 387.00M | 394.80M | 405.10M |
| EPS Basic | 2.62 | 1.38 | -0.34 | -0.27 | -0.44 |
| Normalized Basic EPS | 3.64 | 2.29 | 1.90 | 2.30 | 2.46 |
| EPS Diluted | 2.58 | 1.37 | -0.34 | -0.28 | -0.44 |
| Normalized Diluted EPS | 3.59 | 2.27 | 1.89 | 2.30 | 2.46 |
| Average Basic Shares Outstanding | 147.10M | 148.90M | 150.00M | 150.40M | 150.40M |
| Average Diluted Shares Outstanding | 148.40M | 149.70M | 150.30M | 150.50M | 150.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |